Vocalis Identifies Vocal COVID-19 Biomarker; Announces Clinical Results And CE Mark
Executive Summary
Vocalis plans to roll out smartphone app that can “hear” COVID-19.
You may also be interested in...
Trial Shows Lateral Flow Antibody Testing Could Be Used To Assess COVID-19 Vaccine Efficacy
Abingdon Health has announced that a study run in conjunction with the UK Rapid Test Consortium has demonstrated that its AbC-19 test could be an effective tool for testing vaccine efficacy.
Device Week, 19 February 2021 – A Mix Of Insulin Pump; Liquid Biopsy; Transcatheter Device News
In this week’s podcast, Medtech Insight's managing editor Marion Webb discusses Guardant Health’s launch of a new liquid biopsy test to detect early-stage colorectal cancer. Deputy editor Reed Miller discusses Canadian-based Neovasc’s recent funding and what it could mean for its Reducer transcatheter technology. UK-based reporter Barnaby Pickering gives an overview of the fast-growing insulin pump market.
FDA Approves Shockwave Coronary Intravascular Lithotripsy System
Shockwave Medical received a FDA premarket approval for its C2 coronary intravascular lithotripsy-based calcification remedy and announced its 2020 results, in line with expectations.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: